These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15291656)

  • 1. The current understanding of lamotrigine as a mood stabilizer.
    Hahn CG; Gyulai L; Baldassano CF; Lenox RH
    J Clin Psychiatry; 2004 Jun; 65(6):791-804. PubMed ID: 15291656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine: a review of its use in bipolar disorder.
    Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
    Drugs; 2003; 63(19):2029-50. PubMed ID: 12962521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine update and its use in mood disorders.
    Hurley SC
    Ann Pharmacother; 2002 May; 36(5):860-73. PubMed ID: 11978166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spotlight on lamotrigine in bipolar disorder.
    Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
    CNS Drugs; 2004; 18(1):63-7. PubMed ID: 14731061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine and the treatment of mania in bipolar disorder.
    Berk M
    Eur Neuropsychopharmacol; 1999 Aug; 9 Suppl 4():S119-23. PubMed ID: 10524838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder.
    Xie X; Hagan RM
    Neuropsychobiology; 1998 Oct; 38(3):119-30. PubMed ID: 9778599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
    Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
    Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders.
    Ketter TA; Manji HK; Post RM
    J Clin Psychopharmacol; 2003 Oct; 23(5):484-95. PubMed ID: 14520126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance therapies in bipolar disorder: focus on randomized controlled trials.
    Muzina DJ; Calabrese JR
    Aust N Z J Psychiatry; 2005 Aug; 39(8):652-61. PubMed ID: 16050919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature.
    Ketter TA; Calabrese JR
    J Clin Psychiatry; 2002 Feb; 63(2):146-51. PubMed ID: 11874216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine: a depression mood stabiliser.
    Herman E
    Eur Neuropsychopharmacol; 2004 May; 14 Suppl 2():S89-93. PubMed ID: 15142613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH; McNamara RK; Watterson JM; Watson DG
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiepileptic drugs and mood stability.
    Amann B; Grunze H; Vieta E; Trimble M
    Clin EEG Neurosci; 2007 Apr; 38(2):116-23. PubMed ID: 17515177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implications.
    Seo HJ; Chiesa A; Lee SJ; Patkar AA; Han C; Masand PS; Serretti A; Pae CU
    Clin Neuropharmacol; 2011; 34(1):39-47. PubMed ID: 21242744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mood stabilizers--past, present and future].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Mar; 10(1):31-42. PubMed ID: 18771018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
    Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
    J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder.
    Muzina DJ; Elhaj O; Gajwani P; Gao K; Calabrese JR
    Acta Psychiatr Scand Suppl; 2005; (426):21-8. PubMed ID: 15833097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine for bipolar disorder: translating research into clinical practice.
    Fung J; Mok H; Yatham LN
    Expert Rev Neurother; 2004 May; 4(3):363-70. PubMed ID: 15853534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials.
    Frye MA; Yatham LN; Calabrese JR; Bowden CL; Ketter TA; Suppes T; Adams BE; Thompson TR
    J Clin Psychiatry; 2006 Nov; 67(11):1721-8. PubMed ID: 17196051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.